Cytogam

Indicated For

cytomegalovirus prophylaxis post kidney, lung, liver, pancreas, heart transplant

About This Medication

# Cytogam Patient Guide: How to Get Cytogam at Low or No Cost Cytogam (cytomegalovirus immune globulin intravenous, or CMV-IGIV) is a specialized medication used to prevent cytomegalovirus (CMV) infection in patients undergoing organ transplants, such as kidney, liver, lung, pancreas, or heart transplants.[10][6][9] **Unfortunately, Saol Therapeutics, the manufacturer of Cytogam, does not currently offer a dedicated patient assistance program (PAP) for free or low-cost medication.** This guide explains what is known about access options, eligibility considerations, insurance coverage, and steps to explore financial help, based on available information.[1][8][9] ## About Cytogam Cytogam provides passive immunity against CMV, a common virus that can cause serious infections in transplant patients whose immune systems are suppressed.[10] It is administered intravenously, typically as part of a prophylaxis regimen starting before or around the time of transplant and continuing for several weeks.[6][7] Clinical studies show it reduces the risk of primary CMV disease by about 50% in renal transplant recipients and improves survival in liver transplants when used with other antivirals like ganciclovir.[6][7] **Who might need it?** Primarily patients at high risk, such as CMV-seronegative recipients of organs from CMV-seropositive donors. It's given in a hospital or clinic setting under medical supervision due to potential side effects like allergic reactions, kidney issues, or changes in blood viscosity.[7] Always discuss risks and benefits with your transplant team. ## Who Qualifies for Assistance? No specific patient assistance program exists from Saol Therapeutics for Cytogam.[9] Eligibility for any support would depend on general financial aid pathways, insurance, or specialty pharmacy options. Key factors include: - **Medical need:** Confirmed by your physician for CMV prophylaxis post-transplant.[10] - **Financial hardship:** Programs like independent foundations may consider income, but no Saol-specific thresholds are published (e.g., no FPL percentages or family size limits).[1][9] Since details are unavailable, contact Saol directly at 1-833-644-4216 (pharmacovigilance line, which may route inquiries) or your transplant coordinator for case-by-case funding requests.[6][7] ## Income Eligibility Breakdown **Saol Therapeutics does not publish income eligibility criteria for Cytogam assistance.** Without a formal PAP, there's no standard table of thresholds. Here's a general overview of how PAPs typically work (for reference, not specific to Cytogam): | Household Size | Typical Low-Income Threshold (e.g., 400-500% FPL) | Notes | |---------------|---------------------------------------------------|-------| | Individual | ~$60,000-$75,000 annually | Varies by program; uninsured or underinsured prioritized | | Couple | ~$80,000-$100,000 annually | Family size adjustments common | | Family of 3 | ~$100,000-$125,000 annually | Add ~$20,000 per additional member | | Family of 4 | ~$120,000-$150,000 annually | Proof like tax returns required | *These are illustrative based on common U.S. PAPs; Cytogam has no confirmed program.*[9] Check independent foundations via resources like NeedyMeds or RxAssist. ## Insurance Requirements Cytogam is often covered by commercial insurance and **Medicare Part B** for eligible transplant patients, as it's an injectable biologic.[8] HCPCS code **J0850** (per vial) is used for billing, with national median reimbursement around $1,950 per unit (as of late 2025).[8][9] - **Government insurance:** Medicare covers it for prophylaxis; no manufacturer co-pay cards for Medicare/Medicaid patients.[4] - **Private insurance:** Many plans reimburse fully or partially; prior authorization likely required.[8] - **Uninsured/underinsured:** Explore specialty distributors (e.g., FFF Enterprises) or compassionate use via physician request, though not guaranteed.[2][6] Patients with government plans may qualify for independent charitable foundations.[4] ## Step-by-Step Application Process **No standard application form exists for a Cytogam PAP.**[9] Here's how to pursue access: 1. **Consult your physician:** Discuss CMV risk and Cytogam need; they initiate any requests.[2] 2. **Check insurance coverage:** Submit prior authorization with J0850 code.[8] 3. **Contact Saol Therapeutics:** Call 1-833-644-4216 or visit saolrx.com to inquire about funding/exceptional access (physician-led).[1][6][7] 4. **Use specialty distributors:** Order via partners like FFF Enterprises; they handle reimbursement.[6][8] 5. **Explore external aid:** - Call PAN Foundation or HealthWell Foundation (transplant-focused). - Use BMS Access Support (1-800-861-0048) for foundation referrals, even if not BMS product.[4][5] 6. **Submit documents:** Typically proof of income, prescription, insurance denial (if applicable). Your transplant center's financial counselor can guide this process. ## Timeline and Delivery Processing varies; no PAP means no fixed timeline.[9] Insurance approvals take 1-14 days; specialty pharmacy delivery is 1-3 business days post-approval.[8] Expanded access requests (if applicable) aim for 7-day response but may extend.[2] Cytogam is shipped frozen to hospitals/clinics for IV infusion—not home delivery.[6] ## Alternatives if Denied - **Switch to ganciclovir/valganciclovir** (antivirals) per guidelines, often combined with Cytogam.[6] - **Independent foundations:** PAN, HealthWell, or Patient Access Network.[4] - **Manufacturer inquiry:** Physician submits exceptional funding request.[1] - **Clinical trials:** Check ClinicalTrials.gov for CMV prophylaxis studies. - **Biosimilars:** None available for Cytogam.[ ] ## Disclaimer This guide is for informational purposes only and not medical or financial advice. No dedicated Cytogam PAP is confirmed; coverage/eligibility varies.[9] Consult your healthcare provider, insurer, or financial advisor. Saol disclaims guarantees for access.[2] Information current as of available data; programs change. Report side effects to Saol at 1-833-644-4216.[7] (Word count: 942)

Program information last verified: March 30, 2026